• Regulatory tracker: NICE urges against future Lumakras reimbursement in UK Fierce Pharma Fri, 10 Jul 2026 17:46:45 GMT
• Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout Yahoo Finance Fri, 10 Jul 2026 16:04:38 GMT
• exclusive-us fda to ask sarepta to stop shipments of gene therapy elevidys, source says AOL.com Fri, 10 Jul 2026 08:37:03 GMT
• SRPT Maintained by Piper Sandler -- Price Target Lowered to $20. GuruFocus Thu, 09 Jul 2026 16:22:59 GMT
• SRPT Upgraded by Wolfe Research -- Rating Changed to Outperform GuruFocus Thu, 09 Jul 2026 14:04:49 GMT
• This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next TradingView Thu, 09 Jul 2026 11:03:44 GMT
• Wolfe Research upgrades Sarepta Therapeutics stock rating on pipeline outlook Investing.com Wed, 08 Jul 2026 22:07:00 GMT
• Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy Stocktwits Wed, 08 Jul 2026 08:59:58 GMT
• price to book forward of sarepta therapeutics, inc. – lse:0l35 TradingView Tue, 07 Jul 2026 23:31:43 GMT
• Why Sarepta Therapeutics (SRPT) Is Up 12.7% After FDA Accepts sNDAs Backed By ESSENCE Data simplywall.st Tue, 07 Jul 2026 16:40:26 GMT
• regulatory tracker: abbvie, genmab's blood cancer bispecific expands label in eu Fierce Pharma Tue, 07 Jul 2026 07:00:00 GMT
• Enterprise value to EBITDA forward of Sarepta Therapeutics, Inc. – LSE:0L35 TradingView Tue, 07 Jul 2026 01:43:49 GMT
• FDA Action Update, June 2026: Acceptances, Clearances, and Alignments NeurologyLive Mon, 06 Jul 2026 22:15:32 GMT
• enterprise value to ebit forward of sarepta therapeutics, inc. – lse:0l35 TradingView Sun, 05 Jul 2026 22:30:32 GMT
• sarepta announces fda acceptance of sndas for amondys 45® and vyondys 53® Sarepta Therapeutics Sun, 05 Jul 2026 19:28:42 GMT
• sarepta announces fda acceptance of sndas for amondys 45® and vyondys 53® Sarepta Therapeutics Sat, 04 Jul 2026 06:34:49 GMT
• Price to sales forward of Sarepta Therapeutics, Inc. – NASDAQ:SRPT TradingView Fri, 03 Jul 2026 09:11:01 GMT
• Sarepta Therapeutics, Inc. Stock 12‑Month Price Target Cut to $22, Implies 14% Upside TradingView Fri, 03 Jul 2026 03:20:00 GMT
• regulatory tracker: fda sets decision date for sarepta's dmd drugs Fierce Pharma Wed, 01 Jul 2026 18:10:00 GMT
• sarepta moves closer to fda approval for duchenne muscular dystrophy drugs Sahm Wed, 01 Jul 2026 13:55:53 GMT
• Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail BioSpace Wed, 01 Jul 2026 12:01:50 GMT
• H.C. Wainwright Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating, Maintains Target Price $5 Moomoo Wed, 01 Jul 2026 10:33:00 GMT
• FDA Accepts Sarepta's sNDAs for Casimersen and Golodirsen for Duchenne Muscular Dystrophy NeurologyLive Wed, 01 Jul 2026 03:10:36 GMT
• Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire Tue, 30 Jun 2026 20:25:00 GMT
• FDA Accepts sNDAs for Sarepta's AMONDYS 45 and VYONDYS 53, Targeting Traditional Approval in Duchenne BioPharm International Tue, 30 Jun 2026 18:47:48 GMT
• fda accepts sarepta's applications for full approval of two dmd treatments Intellectia AI Tue, 30 Jun 2026 17:05:32 GMT
• sarepta moves closer to fda approval for duchenne muscular dystrophy drugs Benzinga Tue, 30 Jun 2026 16:44:41 GMT
• sarepta (srpt) seeks traditional approval for duchenne therapies GuruFocus Tue, 30 Jun 2026 16:24:41 GMT
• sarepta stock jumps as fda accepts dmd drug applications by investing.com Investing.com Nigeria Tue, 30 Jun 2026 15:25:12 GMT
• sarepta’s fda decision date; flare gets anna protopapas as ceo Endpoints News Tue, 30 Jun 2026 14:43:00 GMT
• fda accepts sarepta filings for two duchenne therapies Investing.com Tue, 30 Jun 2026 13:19:43 GMT
• Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53® Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Sarepta Therapeutics (SRPT) Following FDA Filings And The Case For A Reset Valuation simplywall.st Tue, 30 Jun 2026 07:00:00 GMT
• SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications Moomoo Tue, 30 Jun 2026 07:00:00 GMT
• sarepta therapeutics, inc.(nasdaqgs: srpt) dropped from russell 1000 index marketscreener.com Mon, 29 Jun 2026 21:58:30 GMT
• sarepta therapeutics, inc.(nasdaqgs: srpt) added to russell 2000 index marketscreener.com Mon, 29 Jun 2026 18:27:01 GMT
• sarepta therapeutics, inc.(nasdaqgs:srpt) dropped from russell midcap growth benchmark marketscreener.com Mon, 29 Jun 2026 16:47:01 GMT
• sarepta therapeutics (srpt) stock analysis: unveiling a 30% potential upside in the biotech sector DirectorsTalk Interviews Mon, 29 Jun 2026 09:25:43 GMT
• sarepta therapeutics, inc.(nasdaqgs: srpt) added to russell 2000 dynamic index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• sarepta therapeutics, inc.(nasdaqgs: srpt) dropped from russell midcap index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• sarepta therapeutics, inc.(nasdaqgs:srpt) dropped from russell midcap value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• sarepta therapeutics rises as gene therapy outlook strengthens StocksToTrade Fri, 26 Jun 2026 20:48:00 GMT
• Sarepta Therapeutics Stock Firms As Gene Therapy Tailwinds Build timothysykes.com Fri, 26 Jun 2026 20:08:00 GMT
• capricor or sarepta: two dmd stocks enter a high-stakes week – which one has more upside? Stocktwits Fri, 26 Jun 2026 19:37:20 GMT
• sarepta shares rise as company begins enrollment in gene therapy safety enhancement study Stocktwits Fri, 26 Jun 2026 06:28:47 GMT
• sarepta therapeutics, inc. shs unsponsored brazilian depository receipt repr 0.05 sh TradingView Thu, 25 Jun 2026 12:21:42 GMT
• sarepta shares rise as company begins enrollment in gene therapy safety enhancement study Stocktwits Wed, 24 Jun 2026 17:16:56 GMT
• how sarepta therapeutics inc. (srpt) affects rotational strategy timing Stock Traders Daily Tue, 23 Jun 2026 17:08:02 GMT
• barclays maintains sarepta therapeutics(srpt.us) with hold rating, maintains target price $20 Moomoo Mon, 22 Jun 2026 09:31:00 GMT
• sarepta therapeutics, inc. (srpt) stock analysis: unlocking a 25.5% upside in the biotech sector DirectorsTalk Interviews Mon, 22 Jun 2026 09:27:04 GMT
• sarepta therapeutics (srpt) stock could be 19% undervalued as elevidys outlook steadies simplywall.st Sun, 21 Jun 2026 07:00:00 GMT
• Is Sarepta (SRPT) Quietly Recasting Its Story Around siRNA as Elevidys Awaits Regulators? simplywall.st Fri, 19 Jun 2026 17:43:49 GMT
• analysts offer insights on healthcare companies: owlet (owlt), praxis precision medicines (prax) and sarepta therapeutics (srpt) The Globe and Mail Fri, 19 Jun 2026 11:54:00 GMT
• sarepta shares rise as company begins enrollment in gene therapy safety enhancement study Stocktwits Fri, 19 Jun 2026 02:08:25 GMT
• sarepta's elevidys showing signs of stabilization as sirna pipeline gains importance, rbc says marketscreener.com Thu, 18 Jun 2026 15:05:52 GMT
• sarepta therapeutics: driving duchenne leadership while expanding a high-potential gene therapy and sirna pipeline Kalkine Thu, 18 Jun 2026 13:44:50 GMT
• sarepta: caution still warranted despite fda's gene therapy friendly stance (nasdaq:srpt) Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• sarepta therapeutics options trading jumps to 5,295 contracts Investing.com Thu, 18 Jun 2026 05:24:56 GMT
• sarepta therapeutics inc (srpt) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 11:51:40 GMT
• Sarepta Therapeutics options trading jumps to 5,295 contracts Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• sarepta therapeutics inc at td cowen healthcare conference transcript GuruFocus Mon, 15 Jun 2026 10:13:44 GMT
• Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a Potential 43.7% Upside in the Biotech Sector DirectorsTalk Interviews Mon, 15 Jun 2026 07:00:00 GMT
• why is sarepta therapeutics (srpt) down 19.9% since last earnings report? MSN Fri, 12 Jun 2026 12:28:48 GMT
• sarepta therapeutics (srpt) q1 earnings and revenues top estimates MSN Thu, 11 Jun 2026 14:58:11 GMT
• ing groep nv cuts stock holdings in sarepta therapeutics, inc. $srpt MarketBeat Wed, 10 Jun 2026 11:37:48 GMT
• why is sarepta therapeutics (srpt) down 19.9% since last earnings report? MSN Wed, 10 Jun 2026 07:25:48 GMT
• sarepta therapeutics (srpt) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Mon, 08 Jun 2026 16:17:47 GMT
• sarepta therapeutics inc at goldman sachs healthcare conference transcript GuruFocus Mon, 08 Jun 2026 14:40:00 GMT
• is sarepta therapeutics (srpt) quietly rewriting its risk profile with new equity plans and q1 profitability? simplywall.st Mon, 08 Jun 2026 11:21:08 GMT
• why is sarepta therapeutics (srpt) down 19.9% since last earnings report? MSN Mon, 08 Jun 2026 10:42:46 GMT
• All You Need to Know About Sarepta Therapeutics (SRPT) Rating Upgrade to Buy Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• Is Sarepta (SRPT) Using New Equity Plans To Quietly Redefine Its Post‑Profitability Playbook? Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• sarepta therapeutics, inc. $srpt shares sold by bnp paribas financial markets MarketBeat Sun, 07 Jun 2026 07:40:31 GMT
• why is sarepta therapeutics (srpt) down 19.9% since last earnings report? MSN Sat, 06 Jun 2026 10:58:45 GMT
• a look at sarepta therapeutics (srpt) valuation after new shelf registration for potential share offering simplywall.st Sat, 06 Jun 2026 01:36:07 GMT
• sarepta therapeutics (srpt) director receives 16,875 rsus equity grant Stock Titan Sat, 06 Jun 2026 00:21:06 GMT
• sarepta (srpt) director gets 16,875 rsus vesting after one year Stock Titan Sat, 06 Jun 2026 00:21:06 GMT
• sarepta (srpt) grants director 16,875 rsus with one-year vesting Stock Titan Sat, 06 Jun 2026 00:21:06 GMT
• sarepta (srpt) director receives 16,875 rsus in stock grant Stock Titan Sat, 06 Jun 2026 00:21:06 GMT
• director at sarepta (nasdaq: srpt) receives 16,875 rsus as equity grant Stock Titan Sat, 06 Jun 2026 00:21:06 GMT
• improving profitability supports sarepta therapeutics inc. (srpt) as one of the most shorted small-cap stocks to buy Yahoo Finance Sat, 06 Jun 2026 00:18:00 GMT
• sarepta therapeutics | 4: statement of changes in beneficial ownership of securities-director mayo stephen Moomoo Sat, 06 Jun 2026 00:10:38 GMT
• sarepta (srpt) awards director barry richard 16,875 rsus Stock Titan Sat, 06 Jun 2026 00:07:04 GMT
• sarepta shares rise as company begins enrollment in gene therapy safety enhancement study Stocktwits Fri, 05 Jun 2026 21:29:54 GMT
• sarepta hits fresh hurdle as court revives patent lawsuit with regenxbio over muscular disorder therapy Stocktwits Fri, 05 Jun 2026 20:20:33 GMT
• Improving Profitability Supports Sarepta Therapeutics Inc. (SRPT) as One of the Most Shorted Small-Cap Stocks to Buy Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report? Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• director at sarepta (nasdaq: srpt) receives 16,875 rsus as equity grant Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta faces earnings test as elevidys slows, sirna pipeline builds by investing.com Investing.com Nigeria Fri, 05 Jun 2026 07:00:00 GMT
• sarepta (srpt) grants director 16,875 rsus with one-year vesting Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta (srpt) director gets 16,875 rsus vesting after one year Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta (srpt) director receives 16,875 rsus in stock grant Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta therapeutics (srpt) director receives 16,875 rsus equity grant Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta (srpt) awards director barry richard 16,875 rsus Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• sarepta therapeutics adopts 2026 equity incentive and employee stock purchase plans – 8-k sec filing summary Minichart Fri, 05 Jun 2026 05:23:00 GMT
• earnings call transcript: sarepta’s q1 2026 earnings beat expectations Investing.com Fri, 05 Jun 2026 01:50:38 GMT
• a quick look at today's ratings for sarepta therapeutics(srpt.us), with a forecast between $5 to $38 富途牛牛 Thu, 04 Jun 2026 20:12:50 GMT
• sarepta (srpt) investors approve 2026 stock plans, director slate and kpmg Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• acting us fda chief meets with rare disease groups to mend fences marketscreener.com Wed, 03 Jun 2026 19:11:25 GMT
• Sarepta Therapeutics to Participate in Upcoming Investor Conferences Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 23% Potential Upside in the Biotech Arena DirectorsTalk Interviews Mon, 01 Jun 2026 07:00:00 GMT
• number of shareholders of sarepta therapeutics, inc. – mil:1srpt TradingView Fri, 29 May 2026 07:38:11 GMT
• sarepta therapeutics stock (us8036071004): focus on valuation as gene therapy franchise develops AD HOC NEWS Fri, 29 May 2026 04:34:56 GMT
• duchenne muscular dystrophy market emerging as a high-growth healthcare investment space through 2036 – delveinsight | ptc therape... Barchart.com Thu, 28 May 2026 21:50:36 GMT
• sarepta therapeutics, inc. (srpt) stock price, news, quote & history Yahoo Finance Thu, 28 May 2026 17:01:46 GMT
• sarepta therapeutics, inc. (srpt) stock price, news, quote & history Yahoo Finance Wed, 27 May 2026 22:29:09 GMT
• In Solid Cash Position, Sarepta Therapeutics Inc (SRPT) Outlines 2026 Priorities Yahoo Finance Wed, 27 May 2026 07:00:00 GMT
• REGENXBIO, Novartis, Dyne near FDA submissions in muscular dystrophies BioSpace Tue, 26 May 2026 07:00:00 GMT
• a look at sarepta therapeutics (srpt) valuation after recent share price weakness and elevidys safety concerns simplywall.st Tue, 26 May 2026 07:00:00 GMT
• assessing sarepta therapeutics (srpt) valuation after recent share price weakness Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• sarepta therapeutics, inc. (srpt) stock analysis: exploring the 30.95% potential upside DirectorsTalk Interviews Mon, 25 May 2026 09:18:58 GMT
• Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
• sarepta's q1 earnings & sales beat estimates, '26 outlook maintained MSN Sun, 24 May 2026 04:33:59 GMT
• why sarepta therapeutics stock surged nearly 48% in after-hours trading today MSN Fri, 22 May 2026 20:01:36 GMT
• 1srpt.mi stock price, quote & chart | sarepta therapeutics inc (bit:1srpt) ChartMill Fri, 22 May 2026 07:00:00 GMT
• united states duchenne muscular dystrophy therapeutics market openPR.com Thu, 21 May 2026 09:21:18 GMT
• Why Elevidys Matters For Sarepta Therapeutics Inc (SRPT) Stock Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• which is a better investment, sarepta therapeutics, inc. or xenon pharmaceuticals inc. stock? AAII Tue, 19 May 2026 08:21:35 GMT
• which is a better investment, syndax pharmaceuticals, inc. or sarepta therapeutics, inc. stock? AAII Tue, 19 May 2026 01:17:40 GMT
• sarepta's q1 earnings & sales beat estimates, '26 outlook maintained MSN Mon, 18 May 2026 14:46:38 GMT
• rare disease therapeutics market 2025-2033 | market growth openPR.com Mon, 18 May 2026 11:25:52 GMT
• sarepta therapeutics, inc. (srpt) stock analysis: exploring a 24.58% potential upside in the biotech sector DirectorsTalk Interviews Mon, 18 May 2026 07:00:00 GMT
• neuromuscular disease therapeutics market to reach usd 45.62 openPR.com Mon, 18 May 2026 06:06:15 GMT
• stockwatch: regenxbio tumbles despite positive pivotal data for dmd gene therapy candidate Genetic Engineering and Biotechnology News Mon, 18 May 2026 01:52:24 GMT
• sarepta therapeutics stock (us8036071004): fda scrutiny keeps investors focused AD HOC NEWS Sun, 17 May 2026 13:41:56 GMT
• sarepta therapeutics: buy rating reiterated on elevidys uptake outlook and microdystrophin validation; $35 price target unchanged TipRanks Fri, 15 May 2026 13:41:14 GMT
• sarepta therapeutics (srpt) soars 35.0%: is further upside left in the stock? Eastern Progress Fri, 15 May 2026 01:55:45 GMT
• regenxbio reaps pivotal win for duchenne gene therapy Fierce Biotech Thu, 14 May 2026 11:25:00 GMT
• regenxbio says duchenne gene therapy succeeded in clinical trial, paving way for fda submission statnews.com Thu, 14 May 2026 11:00:36 GMT
• regenxbio's duchenne study succeeded. will it be enough to convince the fda? Endpoints News Thu, 14 May 2026 11:00:00 GMT
• we don't think sarepta therapeutics' (nasdaq:srpt) earnings should make shareholders too comfortable Moomoo Thu, 14 May 2026 10:51:35 GMT
• sarepta therapeutics stock (us8036071004): q1 earnings beat estimates amid share price decline AD HOC NEWS Thu, 14 May 2026 10:40:51 GMT
• sarepta therapeutics (srpt) q1 earnings and revenues top estimates MSN Thu, 14 May 2026 07:08:48 GMT
• Sarepta Therapeutics' (NASDAQ:SRPT) Earnings Are Built On Soft Foundations Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Sarepta Therapeutics (NASDAQ:SRPT) Is Posting Solid Earnings, But It Is Not All Good News simplywall.st Thu, 14 May 2026 07:00:00 GMT
Sarepta Therapeutics (NASDAQ:SRPT) 
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscul...
Website: http://www.sarepta.com
Founded: 1980
Full Time Employees: 743
Sector: Healthcare
Industry: Biotechnology